Cumberland Pharmaceuticals
CPIX
46 hedge funds and large institutions have $37.2M invested in Cumberland Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
2% more capital invested
Capital invested by funds: $36.4M → $37.2M (+$817K)
0% more funds holding
Funds holding: 46 → 46 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$639K |
| 2 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$252K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$223K |
| 4 |
Renaissance Technologies
New York
|
+$184K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$99.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$2.8M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
-$315K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$71.6K |
| 4 |
Morgan Stanley
New York
|
-$51.8K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$48.1K |
CPIX Hedge Fund Activity: Q2 2015 in Review
46 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2015, worth a combined $37.2M — up 2.2% from $36.4M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CPIX positions and 1 closed out — a net gain of 1 holder — while 16 added to existing stakes and 13 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $639K. The largest seller was Ariel Investments, cutting an estimated $2.8M.
- 46 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $37.2M of Cumberland Pharmaceuticals stock for Q2 2015, up 2.2% quarter-over-quarter.
- 2 funds opened new Cumberland Pharmaceuticals positions in Q2 2015 and 1 closed out, a net change of +1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q2 2015 was Acadian Asset Management, an estimated $639K added.
- The largest Cumberland Pharmaceuticals seller in Q2 2015 was Ariel Investments, an estimated $2.8M sold.
Based on aggregated 13F filings for Q2 2015.